Mandibular Distraction Osteogenesis for Tongue-Based Airway Obstruction Without Micrognathia. Issue 1 (January 2022)

• Record Type: Journal Article
• Authors: Kosyk, Mychajlo S.; Carlson, Anna R.; Zapatero, Zachary D.; Kalmar, Christopher L.; Cielo, Christopher M.; Lioy, Janet; Bartlett, Scott P.; Taylor, Jesse A.; Swanson, Jordan W.
• Is Part Of: Annals of plastic surgery. Volume 88:Issue 1(2022)
• Publication Date: 2022-01
• Subjects: mandibular distraction osteogenesis -- MDO -- distraction -- mandible -- micrognathia; Surgery, Plastic -- Periodicals; 617.95205
• DOI: 10.1097/SAP.0000000000002891
• Languages: English
• ISSNs: 0148-7043

Abstract

Abstract : Purpose: Mandibular distraction osteogenesis (MDO) effectively treats tongue-based airway obstruction (TBAO) in micrognathic patients with Robin Sequence. Mandibular distraction osteogenesis may also address TBAO in certain nonmicrognathic patients who have severe obstructive apnea, although there is no current literature to guide MDO use in these atypical patients. This study describes outcomes of MDO in a series of patients with TBAO without micrognathia. Methods: Patients who underwent MDO for TBAO from 2013–20 were reviewed, and patients with micrognathia were excluded. Study subjects received baseline/follow up polysomnography. Polysomnography variables, including Obstructive Apnea Hypopnea Index, oxyhemoglobin saturation nadir (SpO2 nadir), percent sleep time end tidal CO2 greater than 50 mm Hg (%ETCO2 > 50), and respiratory-related arousals were compared before and after MDO. Demographics, syndromic/cleft palate status, airway anomalies, respiratory support, and feeding outcomes were collected. Results: One hundred and twenty-four patients underwent MDO during this study period; 5 were nonmicrognathic and included in analysis. Sixty percent (n = 3) of the cohort was syndromic: 1 patient each had Trisomy 9, Beckwith Wiedemann syndrome, and duplicated pituitary gland plus syndrome. Forty percent (n = 2) of patients had a cleft palate, 60% (n = 3) had laryngomalacia, and 40% had tracheomalacia. Median (range) age at MDO was 53 days (47–167 days), and median length of distraction was 16 mm (14–20 mm). After MDO, median Obstructive Apnea Hypopnea Index decreased from x[Combining Tilde] = 60.7/h (11.6–109.4) to x[Combining Tilde] = 5.3/h (3.5–19.3) ( P = 0.034). SpO2 nadir increased (69% [58–74] to 85% [80–88], P = 0.011), and median %ETCO2 > 50 mm Hg decreased (5.8% [5.2–30.1] to 0.0% [0.0–1.3], P ⩽ 0.043). Continuous positive airway pressure was used by all patients immediately after MDO, and at 6 months postoperatively, 1 patient remained on continuous positive airway pressure and 1 patient required supplemental oxygen. At last follow up, no patients had significant residual airway obstruction or required a tracheostomy. Conclusions: Mandibular distraction osteogenesis can effectively treat severe TBAO in some patients without micrognathia that would otherwise be candidates for tracheostomy. When used in select patients, MDO significantly improves obstructive sleep apnea and reduces need for ventilatory support, although feeding support is still needed in most patients at 6 months. Further study in a larger cohort will help identify appropriate candidates for MDO and characterize outcomes of unique patient populations.